Skip to content
facebook
twitter
linkedin
youtube
Toggle navigation
L36, 1 Macquarie Place, Sydney, NSW 2000
+61 2 8051 3043
info@raceoncology.com
Home
About
Science
Management team
Investors
News
CONTACT US
×
Contact Us
Δ
Race Submits Human Ethics Application to Commence Cardioprotection Breast Cancer Trial
Browse
Home
ASX Release
Race Submits Human Ethics Application to Commence Cardioprotection Breast Cancer Trial
09
Dec
Dec
, 09 ,
2022
Daniel Tillett
Race-Submits-Human-Ethics-Application-to-Commence-Cardioprotection-Breast-Cancer-Trial
Download
Facebook
Tweet
LinkedIn
Related posts:
Race Oncology 2022 AGM Presentation
Cancer Drug Trial
Race Oncology reveals breakthrough chemotherapy heart protection discovery for Zantrene
Post navigation
Previous
Previous post:
Next
Next post:
Race Oncology
Targeting Zantrene® towards better cancer outcomes
Contact Us
©2023 Race Oncology Ltd |
Privacy Policy
